Skip to content
healthcare.dev

Efavirenz

NDC 33342-013, Efavirenz, tablet, from Macleods Pharmaceuticals Limited.

Product NDC
33342-013
Status
Listed
Labeler
Macleods Pharmaceuticals Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091579
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/33342-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EFAVIRENZ600 mg/1

Pharmacologic classes

Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
33342-013-073334200130730 TABLET in 1 BOTTLE (33342-013-07)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/13ca3456-e5bf-4bb1-af95-b1378658a358

Use it

Look up 33342-013 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/33342-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 33342-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.